Literature DB >> 24889414

Pregnancy in beta-thalassemia intermedia: 20-year experience of a Greek thalassemia center.

Ersi Voskaridou1, Angeliki Balassopoulou, Effrossyni Boutou, Veroniki Komninaka, Dimitrios Christoulas, Maria Dimopoulou, Evangelia-Eleni Delaki, Dimitris Loukopoulos, Evangelos Terpos.   

Abstract

OBJECTIVE: Progress in the management of patients with thalassemia intermedia (TI) enabled increasing rates of pregnancies among TI women worldwide. Nevertheless, information regarding TI pregnancy management and outcome is quite limited in the literature. The aim of this study was to report our experience regarding the maternal and fetal outcome of TI patients, as well as to depict the complexity of the disease and the need for multidisciplinary and personalized management as shown by the description of two interesting pregnancy cases.
METHODS: We analyzed our data recorded from 60 pregnancies in 34 women over a 20-yr period.
RESULTS: Forty-nine patients achieved full-term pregnancies (mean maternal age ± SD: 27.4 ± 6.5 yr) within 37 ± 3 gestation weeks. Their mean hemoglobin value was 8.33 ± 1.22 g/dL; 26.5% of patients were not transfused at all or they had been transfused only once during gestation. There were 11 abortions (18.3%). The spontaneous abortions (5/11) were related to high HbF levels. Six patients had more than two normal deliveries. Nineteen newborns (38.8%), which weighed 2-3 kg, required hospitalization to an intensive neonatal care unit for 1-3 wk. One patient presented with life-threatening complications (hemolytic anemia, thrombocytopenia, and enlargement of spleen) and another with spastic paraparesis due to extramedullary paravertebral masses.
CONCLUSIONS: Although several complications can occur during a pregnancy in TI women, the careful and frequent monitoring by both hamatologists and obstetricians can lead to successful deliveries.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  pregnancy; thalassemia intermedia; transfusion

Mesh:

Year:  2014        PMID: 24889414     DOI: 10.1111/ejh.12387

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  Therapeutic effect of Colla corii asini on improving anemia and hemoglobin compositions in pregnant women with thalassemia.

Authors:  Yanfang Li; Hui He; Lilin Yang; Xiangyi Li; Daocheng Li; Songping Luo
Journal:  Int J Hematol       Date:  2016-07-25       Impact factor: 2.490

Review 2.  Pregnancy in Thalassemia.

Authors:  Raffaella Origa; Federica Comitini
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-03-01       Impact factor: 2.576

3.  Gestational Diabetes Mellitus in Pregnant Women with Beta-Thalassemia Minor: A Matched Case-Control Study.

Authors:  Veronica Falcone; Florian Heinzl; Bianca Karla Itariu; Theresa Reischer; Stephanie Springer; Dana Anaïs Muin; Petra Pateisky; Philipp Foessleitner; Johannes Ott; Alex Farr; Klara Rosta
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

4.  Outcome of Pregnancy with Hemoglobinopathy in a Tertiary Care Center.

Authors:  Anahita Chauhan; Madhva Prasad
Journal:  J Obstet Gynaecol India       Date:  2017-11-11

Review 5.  Pregnancy in women with thalassemia: challenges and solutions.

Authors:  George Petrakos; Panagiotis Andriopoulos; Maria Tsironi
Journal:  Int J Womens Health       Date:  2016-09-08

6.  Pregnancy Complications in a-Thalassemia (Hemoglobinopathy H): A Case Study.

Authors:  Marianna Politou; Giorgos Dryllis; Maria Efstathopoulou; Serena Valsami; Faidra-Evangelia Triantafyllou; Athanasia Tsaroucha; Antonios Kattamis; Nikos F Vlahos
Journal:  Case Rep Obstet Gynecol       Date:  2018-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.